Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Boucher

Showing results (121-130 of 180) with videos related to

Pageof 18
Sort By:
AIDS Research and Human Retroviruses|June 9, 2016
A Summary of the First HIV Microbiome Workshop 2015Brett Williams, Paria Mirmonsef, Charles A B Boucher, et al.
AIDS (London, England)|August 30, 2008
Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switchingJulian H Elliott, Lut Lynen, Alexandra Calmy, et al.
Antiviral Therapy|January 24, 2012
Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotypeMilan J Sonneveld, Vincent Rijckborst, Yilmaz Cakaloglu, et al.
Journal of Medical Virology|June 1, 2013
Virological failure and drug resistance during first line anti-retroviral treatment in IndonesiaAzzania Fibriani, Rudi Wisaksana, Agnes Indrati, et al.
Plos One|October 8, 2013
A polymorphism at position 400 in the connection subdomain of HIV-1 reverse transcriptase affects sensitivity to NNRTIs and RNaseH activityDavid W Wright, Ilona P Deuzing, Philippe Flandre, et al.
Journal of Virology|October 31, 2014
Mutation V111I in HIV-2 reverse transcriptase increases the fitness of the nucleoside analogue-resistant K65R and Q151M virusesIlona P Deuzing, Charlotte Charpentier, David W Wright, et al.
Antiviral Therapy|August 1, 2012
Therapy failure resulting from superinfection by a drug-resistant HIV variantMarieke Pingen, Jan L Nouwen, Sander Dinant, et al.
Journal of Cardiovascular Risk|December 29, 1998
International comparison of awareness and attitudes towards coronary risk factor reduction: the HELP study. Heart European Leaders PanelJ Shepherd, V Alcalde, P A Béfort, et al.
ACS Nano|June 11, 2013
Molecular-scale perspective of water-catalyzed methanol dehydrogenation to formaldehydeMatthew B Boucher, Matthew D Marcinkowski, Melissa L Liriano, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 21, 2019
Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058David A M C van de Vijver, Ann-Kathrin Richter, Charles A B Boucher, et al.
Pageof 18

Showing results (121-130 of 180) with videos related to

Sort By:
Pageof 18
AIDS Research and Human Retroviruses|June 9, 2016
A Summary of the First HIV Microbiome Workshop 2015Brett Williams, Paria Mirmonsef, Charles A B Boucher, et al.
AIDS (London, England)|August 30, 2008
Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switchingJulian H Elliott, Lut Lynen, Alexandra Calmy, et al.
Antiviral Therapy|January 24, 2012
Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotypeMilan J Sonneveld, Vincent Rijckborst, Yilmaz Cakaloglu, et al.
Journal of Medical Virology|June 1, 2013
Virological failure and drug resistance during first line anti-retroviral treatment in IndonesiaAzzania Fibriani, Rudi Wisaksana, Agnes Indrati, et al.
Plos One|October 8, 2013
A polymorphism at position 400 in the connection subdomain of HIV-1 reverse transcriptase affects sensitivity to NNRTIs and RNaseH activityDavid W Wright, Ilona P Deuzing, Philippe Flandre, et al.
Journal of Virology|October 31, 2014
Mutation V111I in HIV-2 reverse transcriptase increases the fitness of the nucleoside analogue-resistant K65R and Q151M virusesIlona P Deuzing, Charlotte Charpentier, David W Wright, et al.
Antiviral Therapy|August 1, 2012
Therapy failure resulting from superinfection by a drug-resistant HIV variantMarieke Pingen, Jan L Nouwen, Sander Dinant, et al.
Journal of Cardiovascular Risk|December 29, 1998
International comparison of awareness and attitudes towards coronary risk factor reduction: the HELP study. Heart European Leaders PanelJ Shepherd, V Alcalde, P A Béfort, et al.
ACS Nano|June 11, 2013
Molecular-scale perspective of water-catalyzed methanol dehydrogenation to formaldehydeMatthew B Boucher, Matthew D Marcinkowski, Melissa L Liriano, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 21, 2019
Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058David A M C van de Vijver, Ann-Kathrin Richter, Charles A B Boucher, et al.
Pageof 18